Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
phase 3
Biotech
Acelyrin rebounds with psoriatic arthritis victory
Acelyrin's fate rests heavily on lead asset izokibep, with new psoriatic arthritis data expected to reinstall confidence in the program.
Max Bayer
Mar 11, 2024 10:59am
GSK antibiotic shows potential in gonorrhea ahead of UTI filing
Feb 26, 2024 7:32am
Pfizer, Valneva overcome CRO Lyme disease recruitment problems
Dec 5, 2023 3:20pm
‘Potential game changer’ gonorrhea antibiotic meets standard
Nov 2, 2023 11:20am
Moderna's one-two COVID-flu punch matches existing vaccines
Oct 4, 2023 9:55am
Roche puts 'stronger gates' on ph. 3 pipeline to limit failures
Sep 11, 2023 11:15am